NEWS

22/11/2015  BIOSYSTEMS INTERNATIONAL AND RANDOX LABORATORIES ANNOUNCE COMPLETION OF CLINICAL TRIAL AND LICENSING FOR QUANTIPLASMA ANTIBODIES FOR EARLY LUNG CANCER DIAGNOSTICS